Readership
Clinical Pharmacologists, Clinicians, Epidemiologists, Immunologists, Infectious Disease Specialists, Internists, Interventionalists, Pharmacologists, Physician Assistants, Physicians, Physicians - Medicine
Scope
The Journal of Virus Eradication aims to provide a specialist, open-access forum to publish work in the rapidly developing field of virus eradication. The Journal covers all human viruses, in the context of new therapeutic strategies, as well as societal eradication of viral infections with preventive interventions.
The Journal is aimed at the international community involved in the prevention and management of viral infections. It provides an academic forum for the publication of original research into viral reservoirs, viral persistence and virus eradication and ultimately development of cures. All submissions are peer reviewed by experts who work at major international centers of excellence.
The Journal not only publishes original research, but provides an opportunity for opinions, reviews, case studies and comments on the published literature. It focusses on evidence-based medicine as the major thrust in the successful management of viral infections. The Journal encompasses virological, immunological, epidemiological, modelling, pharmacological, pre-clinical and in vitro, as well as clinical, data including but not limited to drugs, immunotherapy and gene therapy. It is an important source of information on the development of vaccine programs and preventative measures aimed at virus eradication.
The Journal has an international Editorial Board comprising of leading experts in the field of innovative research and development of therapies for viral diseases. The Editorial Board is supported by an international Editorial Panel. The Editorial Board and Editorial Panel are involved in the peer-review of papers submitted for publication.
Sponsoring Association(s)
Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM)